Frontlight ResearchEarly access
Diabetic eye disease trials in Germany
5 of 8 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Active, not recruitingA Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
- Where
- Bonn, Mainz, Neubrandenburg, Tuebingen, Ulm
- Age
- 18 years and over
- People
- 175 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06321302 · EU 2023-508891-12-00 - Phase 2Taking peopleA Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
- Where
- Dresden, Duesseldorf, Leipzig, Mannheim, Munster
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06962839 · EU 2024-520384-14-00 - Phase 3Not yet taking people in GermanyA Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
- Where
- Dresden, Frankfurt Am Main, Freiburg im Breisgau, Greifswald, Hamburg, Hanover, Munster, Tuebingen
- Age
- 18 years and over
- People
- 1,104 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07705607 · EU 2026-526787-20-00 - No phaseTaking peopleEarly Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)
- Where
- Düsseldorf
- Age
- 18 years and over
- People
- 200
- Run by
- Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06124586 - Phase 2Active, not recruitingSafety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion
- Where
- Tuebingen
- Age
- 18 years and over
- People
- 12 worldwide
- Run by
- Annexin Pharmaceuticals AB
See details and how to joinNCT07259928 · EU 2026-525349-65-00